PubMatic, a Palo Alto, Calif.-based ad revenue optimization company for online publishers, has raised an undisclosed amount of Series B funding. Return backers include Draper Fisher Jurvetson, Nexus India Capital, and Helion Ventures. The company had raised a $7 million Series A round in early 2008.
3 min read · 16 March 2009
SFJ Pharmaceuticals Inc., a platform for bringing U.S. and European drugs to Japan, has raised $45 million in Series A funding, according to VentureWire. Abingworth Management and Clarus Ventures co-led the round, which was designed to help the company acquire its first products. www.sfj-pharma.com (website not currently active)
1 min read · 16 March 2009
NKT Therapeutics Inc., a Newton, Mass.-based developer of therapeutics based on immune cells called natural killer T (NKT) cells, has raised $8 million in Series A funding co-led by SV Life Sciences and MedImmune Ventures.
3 min read · 16 March 2009
3 min read · 16 March 2009
2 min read · 16 March 2009
Covance Inc. (NYSE: CVD) has acquired Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland. No financial terms were disclosed. According to VentureWire, Swiss Pharma raised seed funding in 1998 from Novartis Venture Fund.
2 min read · 15 March 2009
Enzo Biochem Inc. (NYSE: ENZ) has acquired the assets of Assay Designs Inc., an Ann Arbor, Mich.-based provider of immunoassay (ELISA) kits, luminescent reagents, antibodies and proteins for the life sciences research market. The deal was valued at approximately $12.2 million in cash. Assay Designs had raised around $5 million from Ampersand Ventures.
3 min read · 15 March 2009
Numerate Inc., a San Bruno, Calif.-based drug engineering company, has raised around $5.5 million in Series B funding, according to a regulatory filing. Backers include Foundation Capital and Lanza TechVentures. Numerate previously raised $4 million. www.numerate.com
1 min read · 15 March 2009
1 min read · 15 March 2009
Columb Technologies Inc., a Campbell, Calif.-based developer of recharge solutions for electric cars, has raised $3.75 million in Series A funding led by Estag Capital AG.
2 min read · 15 March 2009